Loading news...
Boston Scientific Corporation (BSX) Presents at TD Cowen 46th Annual Health Care Conference Transcript
111 Capital purchased a new stake in shares of Boston Scientific Corporation (NYSE: BSX) during the undefined quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund purchased 30,717 shares of the medical equipment provider's stock, valued at approximately $2,999,000. Other hedge funds and other institutional investors
New York, New York--(Newsfile Corp. - March 2, 2026) - Levi & Korsinsky notifies investors that it has commenced an investigation into Boston Scientific Corporation ("Boston Scientific Corporation") (NYSE: BSX) concerning potential violations of the federal securities laws. On February 4, 2026, Boston Scientific reported fourth-quarter 2025 results.
APG Asset Management N.V. lifted its position in shares of Boston Scientific Corporation (NYSE: BSX) by 5.8% in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 1,061,037 shares of the medical equipment provider's stock after buying an additional
The latest trading day saw Boston Scientific (BSX) settling at $76.85, representing a +1.45% change from its previous close.
DNB Asset Management AS cut its stake in Boston Scientific Corporation (NYSE: BSX) by 9.6% in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 399,330 shares of the medical equipment provider's stock after selling 42,244 shares during the period.
Artisan Partners Limited Partnership reduced its holdings in Boston Scientific Corporation (NYSE: BSX) by 44.2% during the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 4,756,162 shares of the medical equipment provider's stock after selling 3,762,039 shares during the quarter. Artisan Partners
NEW YORK, Feb. 26, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Boston Scientific Corporation ("Boston Scientific" or the "Company") (NYSE: BSX). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext.
Boston Scientific (BSX) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
ALAMEDA, Calif., Feb. 25, 2026 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN), the world's leading thrombectomy company, today reported financial results for the fourth quarter and full year ended December 31, 2025.
Fox Run Management L.L.C. acquired a new position in shares of Boston Scientific Corporation (NYSE: BSX) during the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor acquired 22,606 shares of the medical equipment provider's stock, valued at approximately $2,207,000.
NEW YORK, Feb. 24, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Boston Scientific Corporation (“Boston Scientific” or the “Company”) (NYSE: BSX). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.
Dakota Wealth Management lowered its position in Boston Scientific Corporation (NYSE: BSX) by 48.6% in the undefined quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 122,602 shares of the medical equipment provider's stock after selling 116,064 shares during the period. Dakota Wealth Management's holdings in Boston
Dana Investment Advisors Inc. lessened its position in Boston Scientific Corporation (NYSE: BSX) by 53.7% in the undefined quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 129,863 shares of the medical equipment provider's stock after selling 150,709 shares during the quarter. Dana Investment Advisors
New York, New York--(Newsfile Corp. - February 23, 2026) - Levi & Korsinsky notifies investors that it has commenced an investigation into Boston Scientific Corporation ("Boston Scientific Corporation") (NYSE:BSX) concerning potential violations of the federal securities laws. On February 4, 2026, Boston Scientific reported fourth-quarter 2025 results.
MARLBOROUGH, Mass., Feb. 23, 2026 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) announced today the election of Cathy Smith and Christophe Weber to its Board of Directors, effective February 18, 2026.
Bleakley Financial Group LLC increased its stake in Boston Scientific Corporation (NYSE: BSX) by 9.0% during the third quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 87,392 shares of the medical equipment provider's stock after purchasing an additional 7,232 shares during the quarter. Bleakley Financial
Alliance Wealth Advisors LLC UT increased its position in Boston Scientific Corporation (NYSE: BSX) by 207.7% in the undefined quarter, according to its most recent filing with the SEC. The fund owned 16,560 shares of the medical equipment provider's stock after purchasing an additional 11,178 shares during the period. Alliance Wealth Advisors LLC
Abbott edges out Boston Scientific in the MedTech faceoff, with valuation appeal, strong CGM momentum and strategic deals boosting its investment case.
New York, New York--(Newsfile Corp. - February 19, 2026) - Levi & Korsinsky notifies investors that it has commenced an investigation into Boston Scientific Corporation ("Boston Scientific Corporation") (NYSE: BSX) concerning potential violations of the federal securities laws. On February 4, 2026, Boston Scientific reported fourth-quarter 2025 results.